JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

Search

Thermo Fisher Scientific Inc

Abrir

SetorSaúde

565.95 1.67

Visão Geral

Variação de preço das ações

24h

Atual

Mín

553.91

Máximo

571.44

Indicadores-chave

By Trading Economics

Rendimento

100M

1.6B

Vendas

491M

11B

P/E

Médio do Setor

31.148

37.461

Rendimento de Dividendos

0.3

Margem de lucro

14.878

Funcionários

125,000

EBITDA

1.1B

2.8B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+10.37% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.30%

2.33%

Próxima data de ex-dividendo

12 de dez. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

52B

205B

Abertura anterior

564.28

Fecho anterior

565.95

Sentimento de Notícias

By Acuity

29%

71%

74 / 373 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Thermo Fisher Scientific Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de out. de 2025, 20:49 UTC

Ganhos

Correction to Thermo Fisher Article on Oct. 22

22 de out. de 2025, 10:28 UTC

Ganhos

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

23 de jul. de 2025, 10:33 UTC

Ganhos

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 de jun. de 2025, 21:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 de mai. de 2025, 14:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 de abr. de 2025, 10:33 UTC

Ganhos

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

22 de out. de 2025, 10:01 UTC

Ganhos

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 3Q Adj EPS $5.79 >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 3Q Rev $11.12B >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 3Q Net $1.62B >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 3Q EPS $4.27 >TMO

2 de set. de 2025, 12:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2 de set. de 2025, 12:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2 de set. de 2025, 12:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2 de set. de 2025, 12:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2 de set. de 2025, 12:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2 de set. de 2025, 12:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2 de set. de 2025, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Net $1.62B >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q EPS $4.28 >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Rev $10.85B >TMO

14 de jul. de 2025, 16:12 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 de jul. de 2025, 15:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 de mai. de 2025, 13:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 de abr. de 2025, 10:01 UTC

Ganhos

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q EPS $3.98 >TMO

Comparação entre Pares

Variação de preço

Thermo Fisher Scientific Inc Previsão

Preço-alvo

By TipRanks

10.37% parte superior

Previsão para 12 meses

Média 615.44 USD  10.37%

Máximo 675 USD

Mínimo 561 USD

Com base em 20 analistas de Wall Street que oferecem metas de preço de 12 meses para Thermo Fisher Scientific Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

20 ratings

17

Comprar

3

Manter

0

Vender

Pontuação Técnica

By Trading Central

406.5 / 417.79Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

74 / 373 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat